BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2491971)

  • 1. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).
    Angleton P; Chandler WL; Schmer G
    Circulation; 1989 Jan; 79(1):101-6. PubMed ID: 2491971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
    Eckle T; Bertazzo J; Khatua TN; Fatemi Tabatabaei SR; Moori Bakhtiari N; Walker LA; Martino TA
    Circ Res; 2024 Mar; 134(6):675-694. PubMed ID: 38484024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily rhythms of diabetogenic factors in men: role of type 2 diabetes and body weight.
    Isherwood CM; Robertson MD; Skene DJ; Johnston JD
    Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37855336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of circadian neurovascular function and its implications.
    Mitchell JW; Gillette MU
    Front Neurosci; 2023; 17():1196606. PubMed ID: 37732312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing circadian rhythms-the circadian MEGA bundle as novel approach to treat critical illness.
    Prin M; Bertazzo J; Walker LA; Scott B; Eckle T
    Ann Transl Med; 2023 Jun; 11(9):319. PubMed ID: 37404989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.
    Humphreys SJ; Whyte CS; Mutch NJ
    Front Cardiovasc Med; 2023; 10():1146833. PubMed ID: 37153474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes.
    Yu Y; Li W; Xu L; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1124353. PubMed ID: 37020596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of accelerometer-derived circadian abnormalities and genetic risk with incidence of atrial fibrillation.
    Yang L; Feng H; Ai S; Liu Y; Lei B; Chen J; Tan X; Benedict C; Wang N; Wing YK; Qi L; Zhang J
    NPJ Digit Med; 2023 Mar; 6(1):31. PubMed ID: 36869222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.
    Zheng Z; Mukhametova L; Boffa MB; Moore EE; Wolberg AS; Urano T; Kim PY
    J Thromb Haemost; 2023 Apr; 21(4):1043-1054. PubMed ID: 36759279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights.
    Boinska J; Koziński M; Kasprzak M; Ziołkowski M; Kubica J; Rość D
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy.
    Jasmiad NB; Abd Ghani RB; Agarwal R; Ismail ZB; Mohd Abdullah AA; Idorus MY
    BMC Ophthalmol; 2022 Sep; 22(1):357. PubMed ID: 36057550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease.
    Geng YJ; Smolensky MH; Sum-Ping O; Hermida R; Castriotta RJ
    Chronobiol Int; 2023 Jan; 40(1):33-62. PubMed ID: 35758140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.
    Valke LLFG; Meijer D; Nieuwenhuizen L; Laros-van Gorkom BAP; Blijlevens NMA; van Heerde WL; Schols SEM
    Res Pract Thromb Haemost; 2022 Feb; 6(2):e12681. PubMed ID: 35316940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of Fibrinogen and Fibrinolysis.
    May JE; Wolberg AS; Lim MY
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2.
    Giri A; Srinivasan A; Sundar IK
    Front Neurosci; 2021; 15():674204. PubMed ID: 34220430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.
    Ilich A; Kumar V; Ferrara MJ; Henderson MW; Noubouossie DF; Jenkins DH; Kozar RA; Park MS; Key NS
    Thromb Res; 2021 Aug; 204():22-28. PubMed ID: 34111811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis and bleeding of unknown cause.
    Mehic D; Pabinger I; Ay C; Gebhart J
    Res Pract Thromb Haemost; 2021 May; 5(4):e12511. PubMed ID: 34027290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edoxaban Dosing Time Affects Blood Coagulation Inhibition in Rats.
    Nagata N; Kawasumi M; Fujimura A; Ando H
    TH Open; 2021 Apr; 5(2):e107-e112. PubMed ID: 33870074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian control of human cardiovascular function.
    Thosar SS; Shea SA
    Curr Opin Pharmacol; 2021 Apr; 57():89-97. PubMed ID: 33610933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity.
    Carmona P; Mendez N; Ili CG; Brebi P
    Front Physiol; 2020; 11():129. PubMed ID: 32231582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.